HPC
CORZ icon

Highland Peak Capital’s Core Scientific CORZ Stock Holding History

Highland Peak Capital’s Portfolio CORZ Stock Details CORZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-382,608
Closed -$5.38M – 12
2024
Q4 		$5.38M Sell
382,608
-30,976
-7% -$458K 2.94% 15
2024
Q3 		$4.91M Buy
413,584
+213,584
+107% +$2.21M 2.15% 13
2024
Q2 		$1.86M Buy
+200,000
New +$1.02M 0.65% 16

Other funds holding CORZ

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
M
Murchinson Toronto, Ontario, Canada $791M AUM 68.08% 1-Year Est. Return
GC
Gullane Capital Memphis, Tennessee $37.4M AUM 112.18% 1-Year Est. Return
OWP
ORG Wealth Partners Dallas, Texas $508M AUM 83.62% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $7.15B AUM 169.27% 1-Year Est. Return
JCM
JAT Capital Management Greenwich, Connecticut $59.3M AUM 134.04% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
HPM
Helix Partners Management New York $374M AUM 136.73% 1-Year Est. Return

Highland Peak Capital's CORZ Position: Q1 2025 in Review

Highland Peak Capital sold out of Core Scientific (CORZ) in Q1 2025, closing a stake of 382,608 shares — an estimated $5.38M sold.

Highland Peak Capital first reported a position in CORZ in Q2 2024 and held it in 3 quarters. The position peaked at $5.38M in Q4 2024. 336 funds tracked by Wall St. Rank hold CORZ as of Q1 2025.

  • Highland Peak Capital reported no remaining Core Scientific position as of Q1 2025 after selling out during the quarter.
  • Highland Peak Capital sold 382,608 Core Scientific shares in Q1 2025, an estimated $5.38M.
  • Highland Peak Capital first reported a position in Core Scientific in Q2 2024 and held it in 3 quarters.
  • Highland Peak Capital's Core Scientific position peaked at $5.38M in Q4 2024.
  • 336 funds tracked by Wall St. Rank held Core Scientific as of Q1 2025.

Based on Highland Peak Capital's 13F filing for Q1 2025, filed 9 May 2025.